Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis is the most common cause of erythroderma, and proper medical follow-up is crucial.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Mogamulizumab can cause hair loss and skin rashes.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Benign skin tumors need accurate diagnosis to ensure proper treatment.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The document is a detailed medical reference on skin and genetic disorders.

The document explains various skin conditions and their treatments.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.